|
202-11A8
|
|
|
|
20C2 [4H12:20C2.G6.C9]
|
|
|
|
28-13-3S
|
|
|
|
28-5-15
|
|
|
|
2B7
|
|
|
|
2E6
|
|
|
|
31-3-4S
|
|
|
|
33D1
|
|
|
|
3B-11
|
|
|
|
266-6
|
266-6
|
|
|
204-4
|
|
|
|
26-8-16S
|
|
|
|
28-16-8S
|
|
|
|
2A5
|
|
|
|
2D4
|
|
|
|
310-29F7
|
|
|
|
32B11
|
|
|
|
3A5
|
|
|
|
35.1
|
3,5-二甲氧基苯腈
|
19179-31-8
|
|
23 ScCr [10ScNCr/23]
|
|
|
|
25-9-3S
|
|
|
|
293[HEK-293] Cas9
|
|
|
|
293TT
|
|
|
|
2G3
|
|
|
|
308TAg
|
|
|
|
34-4-20S
|
|
|
|
36F-18C [36F]
|
|
|
|
2D12
|
|
|
|
2E8
|
NCI-BL1339
|
|
|
293 [HEK-293]
|
HEK293(人胚腎細(xì)胞)
|
|
|
203-7D10
|
|
|
|
20H11
|
|
|
|
28-14-8S
|
|
|
|
28S.3
|
|
|
|
2BD4E4 K99
|
|
|
|
2E10-H2
|
|
|
|
2Hx-2
|
|
|
|
34
|
|
|
|
34-5-3S
|
|
|
|
3A(tPA-30-1)
|
|
|
|
20-8-4S
|
|
|
|
26ic
|
|
|
|
28-2-7
|
|
|
|
2AB1-IA10
|
|
|
|
2D-7
|
|
|
|
311-3D4
|
|
|
|
331.12
|
|
|
|
3A9
|
|
|
|
2C4
|
帕妥珠單抗
|
380610-27-5
|
|
293 c18
|
人胚腎細(xì)胞
|
|
|
240-13D10
|
|
|
|
260-33C4
|
|
|
|
293[HEK-293] dCas9-KRAB
|
|
|
|
2A11
|
|
|
|
2G8.D6
|
|
|
|
30-C7
|
|
|
|
34-4-21S
|
|
|
|
38-1
|
|
|
|
293T
|
293t
|
|
|
20H2
|
|
|
|
25-5-16S
|
|
|
|
293.STAT1 BAX KO
|
|
|
|
293T/17 [HEK 293T/17]
|
人胚腎細(xì)胞(活細(xì)胞順豐包郵,或可供凍存管)
|
|
|
2F.11.15
|
|
|
|
2T8-3E10 Mouse Hybridoma (Patent Line)
|
|
|
|
34-1-2S
|
|
|
|
356-1
|
|
|
|
201-45E9
|
|
|
|
209/MDCT
|
|
|
|
28-11-5S
|
|
|
|
283TAg
|
|
|
|
2B5 Mouse Hybridoma
|
|
|
|
2D7F10
|
|
|
|
312-13E8
|
|
|
|
339-1
|
|
|
|
3A-sub E [post crisis of 3A(tPA-30-1)]
|
|
|
|
22Rv1
|
22Rv1
|
|
|
225
|
alpha-三聯(lián)噻吩
|
1081-34-1
|
|
24IA2E2E10D5 [24IA2]
|
|
|
|
26-7-11S
|
|
|
|
293SF-3F6
|
|
|
|
2A3
|
|
|
|
2H-11
|
|
|
|
30-H12
|
|
|
|
3197-3 (3T3-MSV)
|
|
|
|
3-83P
|
|
|
|
3C7.2
|
|
|
|
39-S
|
3-(R) - 羥基奎尼丁
|
60761-51-5
|
|
2PK-3
|
2PK-3 小鼠B淋巴瘤細(xì)胞系
|
|
|
372
|
化合物 T24354
|
159565-60-3
|
|
22D1
|
|
|
|
25-9-17S II
|
|
|
|
293/CHE-Fc
|
|
|
|
293T/17 SF [HEK 293T/17 SF]
|
|
|
|
2F-2B
|
|
|
|
30-5-7S
|
|
|
|
34-2-12S
|
|
|
|
36 (HeteroMyeloma, Human-Mouse)
|
|
|
|
26CB-1
|
3,3',4,4',5-五溴聯(lián)苯醚
|
57465-28-8
|
|
32D Clone 3
|
32D
|
|